Clozapine bioactivation induces dose-dependent, drug-specific toxicity of human bone marrow stromal cells: A potential in vitro system for the study of agranulocytosis
- 1 September 2006
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 72 (6) , 783-793
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Potential clozapine target sites on peripheral hematopoietic cells and stromal cells of the bone marrowThe Pharmacogenomics Journal, 2003
- N-Acetylcysteine Reduced the Effect of Ethanol on Antioxidant System in Rat Plasma and Brain Tissue.The Tohoku Journal of Experimental Medicine, 2002
- Neuropeptide control of bone marrow neutrophil production is mediated by both direct and indirect effects on CFU‐GMBritish Journal of Haematology, 2000
- Drugs that induce neutropenia/agranulocytosis may target specific components of the stromal cell extracellular matrixMedical Hypotheses, 1999
- Mechanism of Clozapine-Induced AgranulocytosisCNS Drugs, 1997
- Possible Involvement of Bone Marrow Stromal Cells in Agranulocytosis Caused by Vesnarinone TreatmentActa Haematologica, 1997
- Murine Marrow Stromal Response to Myelotoxic Agents in vitroBritish Journal of Haematology, 1996
- The extracellular matrix of the hematopoietic microenvironmentCellular and Molecular Life Sciences, 1995
- The effect of histamine on the oxidative burst of HL60 cells before and after exposure to reactive oxygen speciesInflammation Research, 1995
- Regulation of Hemopoiesis by Bone Marrow Stromal Cells and Their ProductsAnnual Review of Immunology, 1990